We are live on ! Find out more
CNTB

Connect Biopharma Holdings
CNTB

29 hedge funds and large institutions have $13M invested in Connect Biopharma Holdings in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

4% more funds holding

Funds holding: 28 → 29 (+1)

3.62% less ownership

Funds ownership: 30.8% → 27.18% (-3.6%)

76% less capital invested

Capital invested by funds: $53.4M → $13M (-$40.4M)

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$959K
2
KCM
Kynam Capital Management
New Jersey
+$754K
3
Citadel Advisors
Citadel Advisors
Florida
+$603K
4
Citigroup
Citigroup
New York
+$551K
5
DCM
DAFNA Capital Management
California
+$368K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.36M
2
RI
RTW Investments
New York
-$1.35M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.3M
4
BlackRock
BlackRock
New York
-$1.18M
5
Barclays
Barclays
United Kingdom
-$947K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$6.08M – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$1.46M +$353K +240,019 +17%
BlackRock
3
BlackRock
New York
$1.25M -$1.18M -801,432 -36%
KCM
4
Kynam Capital Management
New Jersey
$643K +$754K +511,890 +225%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$637K -$1.3M -879,826 -55%
IC
6
Ikarian Capital
Texas
$591K – – –
UOC
7
UBS O'Connor
Illinois
$567K +$959K +651,506 New
SCM
8
Sio Capital Management
New York
$520K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$357K +$603K +409,659 New
Citigroup
10
Citigroup
New York
$327K +$551K +374,314 +35,547%
DCM
11
DAFNA Capital Management
California
$218K +$368K +250,000 New
UBS Group
12
UBS Group
Switzerland
$91K +$152K +103,324 +5,552%
BFM
13
Boothbay Fund Management
New York
$68K – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$58K +$63.9K +43,400 +185%
Two Sigma Investments
15
Two Sigma Investments
New York
$24K +$41.3K +28,016 New
CL
16
CSS LLC
Illinois
$17K – – –
Goldman Sachs
17
Goldman Sachs
New York
$17K +$253 +172 +0.9%
CPIG
18
Chicago Partners Investment Group
Illinois
$17K +$1.56K +1,063 +5%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$16K – – –
VIA
20
Vident Investment Advisory
Georgia
$16K – – –
TRCT
21
Tower Research Capital (TRC)
New York
$15K +$23K +15,584 +1,256%
VF
22
Virtu Financial
New York
$14K +$24.5K +16,658 New
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$12K +$20.3K +13,750 New
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$11K +$19.3K +13,110 New
Morgan Stanley
25
Morgan Stanley
New York
$7K -$1K -681 -8%
1
2

CNTB Hedge Fund Activity: Q2 2022 in Review

29 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q2 2022, worth a combined $13M — down 76% from $53.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CNTB positions and 6 closed out — a net gain of 1 holder — while 9 added to existing stakes and 6 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $959K. The largest seller was Fidelity Investments, cutting an estimated $3.36M.

  • 29 institutional investors held Connect Biopharma Holdings (CNTB) as of Q2 2022, up from 28 in Q1 2022.
  • Funds reported $13M of Connect Biopharma Holdings stock for Q2 2022, down 76% quarter-over-quarter.
  • 7 funds opened new Connect Biopharma Holdings positions in Q2 2022 and 6 closed out, a net change of +1 holder.
  • The largest Connect Biopharma Holdings buyer in Q2 2022 was UBS O'Connor, an estimated $959K added.
  • The largest Connect Biopharma Holdings seller in Q2 2022 was Fidelity Investments, an estimated $3.36M sold.

Based on aggregated 13F filings for Q2 2022.